Question 1

What is the catalog number for Tert-Butyl ((3R,5S) -5- (hydroxymethyl) pyrrolidin-3-yl) carbamate?

Accepted Answer

The catalog number for Tert-Butyl ((3R,5S) -5- (hydroxymethyl) pyrrolidin-3-yl) carbamate is JH916247.

Question 2

What sizes are available for Tert-Butyl ((3R,5S) -5- (hydroxymethyl) pyrrolidin-3-yl) carbamate?

Accepted Answer

Tert-Butyl ((3R,5S) -5- (hydroxymethyl) pyrrolidin-3-yl) carbamate is available in the following size(s): 1 Each.

Question 3

Is Tert-Butyl ((3R,5S) -5- (hydroxymethyl) pyrrolidin-3-yl) carbamate in stock?

Accepted Answer

Tert-Butyl ((3R,5S) -5- (hydroxymethyl) pyrrolidin-3-yl) carbamate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Question 5

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 6

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Tert-Butyl ((3R,5S) -5- (hydroxymethyl) pyrrolidin-3-yl) carbamate

Product Specifications

CAS Number

Molecular Formula

Molecular Weight

Frequently Asked Questions

Explore Other Products

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF405S conjugate, 0.1mg/mL

CD3e (T-Cell Marker) (OKT3), CF488A conjugate, 0.1mg/mL

CD43 (Bra7G), 1mg/mL

Anti-FMN1 Antibody Picoband® (APC Conjugate)

CD73 (Immuno-Oncology Target) (NT5E/2503), 0.2mg/mL

IPO-38 (IPO-38), 1mg/mL